Denali Therapeutics, Inc. (DNLI)

20.47 +0.01 (+0.05%) USD  |  NASDAQ  |  Sep 24, 16:00
20.48 +0.01 (+0.05%) After-Hours: 19:59
More

Denali Therapeutics Gross Profit (Annual) : -14.81M for Dec. 31, 2025

Gross Profit (Annual) Chart

View Gross Profit (Annual) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -14.81M
December 31, 2024 -7.795M
December 31, 2023 313.80M
December 31, 2022 101.43M
December 31, 2021 43.05M
December 31, 2020 0.00
Date Value
December 31, 2019 0.00
December 31, 2018 121.74M
December 31, 2017 -3.082M
December 31, 2016 -1.469M
December 31, 2015 -0.121M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 805.52M
Oncolytics Biotech, Inc. -0.07M
Sangamo Therapeutics, Inc. 31.95M
Sarepta Therapeutics, Inc. 1.314B
Anixa Biosciences, Inc. -0.036M